title: US company's gene therapy trial is first to bypass RAC for approval.
authors.forename: C
authors.initials: C
authors.lastname: Anderson
mesh_terms: D016915:AIDS Vaccines / Q000633:toxicity*; D001675:Bioethics; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D004274:DNA, Recombinant; D004341:Drug Evaluation; D015316:Genetic Therapy / Q000592:standards; D006077:Government Agencies; D006801:Humans; D007221:Industry; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016915:AIDS Vaccines; D004274:DNA, Recombinant